By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


enGene, Inc. 

100-2386 East Mall

Vancouver  British Columbia  V6T 1Z3  Canada
Phone: 604-221-4DNA Ext. 28 Fax: 604-221-4369



Company News
Takeda (TKPYY) And enGene, Inc. Establish Strategic Alliance To Develop Novel Therapeutics For Gastrointestinal Diseases 1/12/2016 12:13:47 PM
enGene, Inc. Annouces The Appointment Of Dr. Dennis H. Langer To The Company's Board Of Directors 12/8/2015 12:22:31 PM
enGene, Inc., Johnson & Johnson (JNJ) Ink Inflammatory Bowel Disease Pact for C $441 Million 10/14/2015 6:54:53 AM
Forbion Capital Partners Leads CAD 13.5 Million (EUR 9.6 Million) Series B Financing Round For enGene, Inc. 1/26/2015 9:43:13 AM
Lumira Capital Announces Investment in enGene, Inc. 8/5/2013 6:46:52 AM
enGene, Inc. CSO to Present Key Pre-Clinical Data on EG-10 for Treating Inflammatory Bowel Disease 12/6/2010 11:28:13 AM
enGene, Inc. Adds Leading Nanomedicine Expert To Scientific Advisory Board 9/2/2010 9:44:10 AM
enGene, Inc. to Present Research Data on EG-10 for Inflammatory Bowel Disease (IBD) 2/25/2010 10:38:33 AM
enGene, Inc. CEO to Present at Rodman & Renshaw Healthcare Conference 8/11/2009 10:22:45 AM
enGene, Inc. Receives NRC-IRAP Contribution, Initiates Convertible Note Financing 6/11/2009 10:16:21 AM